UniSuper Management Pty Ltd Has $5.29 Million Stock Holdings in The Cigna Group (NYSE:CI)

UniSuper Management Pty Ltd cut its stake in shares of The Cigna Group (NYSE:CI - Free Report) by 32.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 19,145 shares of the health services provider's stock after selling 9,074 shares during the quarter. UniSuper Management Pty Ltd's holdings in The Cigna Group were worth $5,287,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in CI. CreativeOne Wealth LLC raised its holdings in shares of The Cigna Group by 3.0% in the third quarter. CreativeOne Wealth LLC now owns 1,219 shares of the health services provider's stock valued at $422,000 after buying an additional 35 shares during the last quarter. Hudson Edge Investment Partners Inc. raised its stake in shares of The Cigna Group by 1.9% in the fourth quarter. Hudson Edge Investment Partners Inc. now owns 1,883 shares of the health services provider's stock worth $520,000 after acquiring an additional 36 shares during the last quarter. Meridian Wealth Management LLC lifted its position in shares of The Cigna Group by 1.0% during the fourth quarter. Meridian Wealth Management LLC now owns 3,670 shares of the health services provider's stock worth $1,013,000 after purchasing an additional 37 shares in the last quarter. Mindset Wealth Management LLC grew its stake in shares of The Cigna Group by 2.6% during the fourth quarter. Mindset Wealth Management LLC now owns 1,469 shares of the health services provider's stock valued at $406,000 after purchasing an additional 37 shares during the last quarter. Finally, Jacobi Capital Management LLC increased its holdings in shares of The Cigna Group by 2.2% in the fourth quarter. Jacobi Capital Management LLC now owns 1,749 shares of the health services provider's stock valued at $483,000 after purchasing an additional 38 shares in the last quarter. Institutional investors own 86.99% of the company's stock.

Remove Ads

The Cigna Group Stock Up 1.3 %

Shares of CI traded up $4.29 during midday trading on Monday, hitting $329.33. The stock had a trading volume of 2,128,567 shares, compared to its average volume of 1,654,150. The company has a 50 day simple moving average of $304.67 and a two-hundred day simple moving average of $313.47. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83. The firm has a market cap of $90.13 billion, a price-to-earnings ratio of 26.91, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72.

The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter in the prior year, the business posted $6.79 earnings per share. On average, analysts anticipate that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 20th. Investors of record on Wednesday, March 5th were given a dividend of $1.51 per share. The ex-dividend date of this dividend was Wednesday, March 5th. This is a boost from The Cigna Group's previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a yield of 1.83%. The Cigna Group's dividend payout ratio is 49.35%.

Analysts Set New Price Targets

Several research firms have issued reports on CI. Wells Fargo & Company reduced their price objective on The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a report on Tuesday, February 4th. Raymond James reaffirmed a "strong-buy" rating and issued a $360.00 target price (down previously from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. Royal Bank of Canada set a $355.00 price target on shares of The Cigna Group in a research note on Friday, January 31st. Oppenheimer reduced their price objective on shares of The Cigna Group from $400.00 to $375.00 and set an "outperform" rating on the stock in a research note on Friday, January 31st. Finally, Barclays lowered their target price on shares of The Cigna Group from $420.00 to $339.00 and set an "overweight" rating for the company in a report on Friday, January 31st. Two equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Buy" and an average price target of $373.25.

Insiders Place Their Bets

In other The Cigna Group news, Director Elder Granger sold 2,376 shares of the business's stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $310.35, for a total transaction of $737,391.60. Following the transaction, the director now owns 5,471 shares of the company's stock, valued at $1,697,924.85. The trade was a 30.28 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Nicole S. Jones sold 4,904 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $1,511,020.48. Following the transaction, the insider now directly owns 29,421 shares in the company, valued at $9,065,198.52. The trade was a 14.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,751 shares of company stock valued at $13,603,991 in the last 90 days. 0.70% of the stock is currently owned by insiders.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.